Dr Tom Kaier, one of the lead researchers, funded by the British Heart Foundation (BHF) at St Thomas’ Hospital, London, said in this article about the novel cardiac biomarker cMyC:
“Our research shows that the new test (cMyC) has the potential to reassure many thousands more patients with a single test, improving their experience and freeing up valuable hospital beds in A&E departments and wards across the country.”
King’s College London carries out around 7,800 troponin blood tests each year. By Tom Kaiers calculations, switching to cMyC from hs-cTn would yearly save the hospital £800,000 through reduced admissions.
“Our research shows that the new test (cMyC) has the potential to reassure many thousands more patients with a single test, improving their experience and freeing up valuable hospital beds in A&E departments and wards across the country.”
King’s College London carries out around 7,800 troponin blood tests each year. By Tom Kaiers calculations, switching to cMyC from hs-cTn would yearly save the hospital £800,000 through reduced admissions.
